The operational shift supports the development of resilient regulatory reporting frameworks capable of adapting to evolving ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

Founder and Chief Scientific Officer at Maisa, is an AI researcher and engineer focused on developing reliable, enterprise-grade artificial intelligence systems. He co-founded Maisa in 2024 to build ...

-Prateek Madhav Co-Founder and CEO, AssisTech Foundation (ATF) ...

Researchers at Pacific Northwest National Laboratory used artificial intelligence to analyze protein nanoribbons, pointing to ...

The U.S. Department of Energy now has two major supercomputing systems aimed at accelerating fusion energy research through ...

As a Senior Software Engineer, you will be at the forefront of Advanced Development. You won't just be maintaining systems; you will be building the "first-of-a-kind" prototypes. You will work ...

A new technical paper, “Towards Structured Training and Validation of AI-based Systems with Digital Twin Scenarios,” was ...

Regulation and the pharmaceutical sector are intrinsically linked. Indeed, it’s no exaggeration to state that the global pharmaceutical sector is one of the most heavily regulated industries in the ...

Authenticity and provenance must be enforced both at the application level and at the system level so agencies can be ...

Officials with the FDA have released a draft guidance that aims to help drug developers validate new approach methodologies (NAMs) that can be used in place of animal testing. Based on human-centric ...